Form 4 for GEHC GE HealthCare
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0002027284-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-04 | 2026-03-02 | GEHC | Rackliffe Philip | CEO, AVS | A - Grant | $0.00 | +9,356 | 26.7K | +54% | $0 |
| D | 2026-03-04 | 2026-03-02 | GEHC | Rackliffe Philip | CEO, AVS | A - Grant | $0.00 | +24.6K | 24.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2026-03-02 | A | A | 9,356 | $0.00 | 26,729 | D | — | — | (F1) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. (F2) Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2026-03-02 | A | A | 24,598 | $0.00 | 24,598 | D | $80.16 · — to 2036-03-02 | 24,598 Common Stock, par value $0.01 per share | (F3) Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |